Form 8-K - Current report:
SEC Accession No. 0001193125-25-291998
Filing Date
2025-11-24
Accepted
2025-11-24 07:10:30
Documents
13
Period of Report
2025-11-24
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d72478d8k.htm   iXBRL 8-K 33025
2 EX-99.1 d72478dex991.htm EX-99.1 25780
  Complete submission text file 0001193125-25-291998.txt   183467

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20251124.xsd EX-101.SCH 2522
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20251124_lab.xml EX-101.LAB 18441
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20251124_pre.xml EX-101.PRE 11232
15 EXTRACTED XBRL INSTANCE DOCUMENT d72478d8k_htm.xml XML 3712
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 251509562
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)